2030 年眼部过敏治疗市场报告(按细分市场、地域、动态、最新发展和战略洞察)

  • Report Code : TIPRE00007418
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Eye Allergy Treatment Market Size, Demand, and Forecast | 2030

Buy Now

【研究报告】眼部过敏治疗市场规模预计将从2022年的35.9亿美元增至2030年的56.9亿美元;预计 2022 年至 2030 年复合年增长率为 5.9%。
市场洞察和分析师观点:
眼部过敏治疗包括非处方药和处方药,用于缓解红肿、瘙痒、流泪、眼睛肿胀。一些常用的产品包括抗组胺滴眼液、肥大细胞稳定剂和联合疗法。眼睛过敏的主要类型是季节性或常年性过敏性结膜炎、春季角结膜炎、特应性角结膜炎和接触性过敏性结膜炎。全球眼部过敏的患病率不断上升,以及非处方解决方案的出现,有利于眼部过敏治疗市场的增长。
增长动力:
眼部过敏,也称为过敏性结膜炎,是由花粉、灰尘、动物和霉菌。空气污染的加剧导致眼睛过敏的发病率不断上升。此外,生活方式和饮食习惯的改变、接触过敏原的增加、导致眼睛疲劳的屏幕时间增加以及眼睛不适的易感性增加,导致全球人口的眼睛过敏反应大幅增加。
根据2020 年发表的题为“过敏性结膜炎的当代观察”的研究表明,过敏性眼病是北美人群中的一个常见问题。它影响了近 40% 的人口,而且这个数字还在增长。一半患有眼部过敏症状的美国人需要药物来缓解。尽管如此,其中只有一小部分人使用处方药,这使得这些新疗法的开发特别有吸引力。
眼睛过敏治疗包括用于治疗和管理影响眼睛的过敏的产品和解决方案。治疗包括非处方药和处方药,用于缓解眼睛发红、瘙痒、流泪和肿胀等症状。一些常用的产品包括抗组胺滴眼液、肥大细胞稳定剂和非甾体抗炎药。患有眼睛过敏的人数增加导致对治疗方案的需求更高。这增加了对治疗选择的需求,从而推动了眼过敏治疗市场的增长。
眼过敏治疗市场趋势包括联合疗法的开发,这将有利于未来市场的增长。
<报告细分和范围:
眼过敏治疗市场分析是通过考虑以下细分进行的:治疗、适应症、分销渠道和地理位置。根据治疗方法,市场分为药物、过敏注射剂和滴眼剂。从适应症来看,市场分为季节性和常年性过敏性结膜炎、春季角结膜炎、特应性角结膜炎、接触性过敏性结膜炎、巨乳头性结膜炎。从分销渠道来看,市场分为医院药房、网上药房和药店。
眼过敏治疗市场报告范围涵盖北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非、中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。
细分分析:
按治疗划分的眼部过敏治疗市场,分为药物、抗过敏注射剂和滴眼剂。滴眼剂细分市场在 2022 年占据了重要的市场份额。预计 2022 年至 2030 年期间将创下市场最高复合年增长率。
根据迹象,市场分为季节性和常年性过敏性结膜炎、春季角结膜炎、特应性结膜炎角结膜炎、接触性过敏性结膜炎、巨乳头性结膜炎。季节性和常年性过敏性结膜炎细分市场在 2022 年占据了显着的眼部过敏治疗市场份额,预计 2022 年至 2030 年复合年增长率最高。
根据分销渠道,市场分为医院药房、在线药房和药店。医院药房部门在 2022 年占据了重要的眼部过敏治疗市场份额。此外,在线药房部门预计在 2022 年至 2030 年期间复合年增长率最高。
按治疗方式划分的眼部过敏治疗市场 – 2022 年和 2030 年
区域分析:
根据地理位置,眼过敏治疗市场报告主要分为北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。 2022 年,北美占据了很大的市场份额。 2022年,美国占据该地区最大的市场份额。北美市场的增长归因于现代医疗基础设施的可用性、主要市场参与者的强大存在、眼睛过敏和干眼病数量的不断增加以及尖端药物的引入。据 Baptist Health 称,近 5000 万美国人患有某种形式的季节性过敏。大约 30% 的成人和 40% 的儿童经历过影响眼睛、眼睑和泪管的过敏反应。
干眼症会导致眼睛过敏,从而导致干眼病。干眼病在美国是一种常见但诊断不足的疾病。根据2020年公布的国家健康与健康调查数据,美国6.8%的成年人被诊断患有干眼症。根据 2019 年发表的一篇文章“墨西哥干眼症患者眼表损伤的风险因素:一项基于人群的研究”,近 58% 的人抱怨干眼症。
制药公司正在改善获得干眼症的机会。专门的治疗方法,例如缓解过敏的眼药水,以扩大其在该地区的覆盖范围。从 2022 年 3 月起,患有眼部过敏的美国人无需处方即可使用艾尔建的 LASTACAFT(0.25% 阿卡他定滴眼液)。继美国食品和药物管理局最近批准从处方到非处方药的全面转换后,LASTACAFT 的原始专利处方强度配方可以在网上和销售 OTC 滴眼剂的零售店找到。因此,上述因素推动了该地区的眼部过敏治疗市场。
行业发展和未来机遇:
以下列出了在全球眼部过敏治疗市场运营的市场参与者采取的一些举措:
2020 年 9 月,雷迪博士实验室在美国市场推出了一种非处方眼部过敏滴眼液——盐酸奥洛他定滴眼液。该溶液可暂时缓解因花粉、草、动物毛发和皮屑引起的眼睛瘙痒。2020 年 2 月,爱尔康获得美国食品和药物管理局批准,推出每天一次的 Pataday 缓解剂和每天两次的 Pataday 缓解剂,以缓解过度发痒的情况。美国专柜销售。 Pataday 品牌采用排名第一的医生处方眼部过敏止痒成分,并包括第一个无需处方即可使用的每日一次过敏止痒滴剂。竞争格局和主要公司:
眼部过敏治疗市场预测可以帮助利益相关者规划他们的增长战略。博士伦、爱尔康、艾伯维、强生、Akorn Inc.、Nicox、参天制药有限公司、梯瓦制药工业有限公司、诺华公司和太阳制药工业有限公司是市场上的知名参与者。这些公司专注于推出新的高科技产品、现有产品的进步以及地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the eye allergy treatment market?

The global eye allergy treatment market is segmented based on treatment, indication, and distribution channel. The eye allergy treatment market, by treatment, is categorized into medication, allergy shots, and eye drops. The eye drops segment held a significant market share in 2022 and is anticipated to record the highest CAGR in the market during 2022–2030.

What was the estimated eye allergy treatment market size in 2022?

The eye allergy treatment market was valued at US$ 3.59 billion in 2022.

What are the growth estimates for the eye allergy treatment market till 2030?

The eye allergy treatment market is expected to be valued at US$ 5.69 billion in 2030.

What is eye allergy treatment?

Eye allergy treatment includes products and solutions that are used to treat and manage allergies affecting the eyes. Treatment includes over-the-counter medications and prescription drugs that are used to alleviate symptoms such as redness, itching, tearing, and swelling of the eyes. Some of the commonly used products include antihistamine eye drops, mast cell stabilizers, and combination therapies.

What is the driving and restraining factors for the eye allergy treatment market?

The factors driving the growth of the eye allergy treatment market include the increasing prevalence of eye allergies worldwide and a significant number of switches from prescription to over-the-counter drugs. However, a lack of awareness of ocular allergies hampers the growth of the eye allergy treatment market.

Who are the major players in the eye allergy treatment market?

The eye allergy treatment market majorly consists of the players, including Bausch + Lomb, Alcon, AbbVie, Johnson & Johnson, Akorn Inc., Nicox, Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Novartis AG, and Sun Pharmaceutical Industries Ltd.

The List of Companies - Eye Allergy Treatment Market

  1. Bausch + Lomb
  2. Alcon
  3. AbbVie
  4. Johnson & Johnson
  5. Akorn Inc.
  6. Nicox
  7. Santen Pharmaceutical Co. Ltd
  8. Teva Pharmaceutical Industries Ltd
  9. Novartis AG
  10. Sun Pharmaceutical Industries Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..